Literature DB >> 21875733

An increase in the number of predictive factors augments the likelihood of malignancy in branch duct intraductal papillary mucinous neoplasm of the pancreas.

Takao Ohtsuka1, Hiroshi Kono, Yosuke Nagayoshi, Yasuhisa Mori, Kosuke Tsutsumi, Yoshihiko Sadakari, Shunichi Takahata, Katsuya Morimatsu, Shinichi Aishima, Hisato Igarashi, Tetsuhide Ito, Kousei Ishigami, Masafumi Nakamura, Kazuhiro Mizumoto, Masao Tanaka.   

Abstract

BACKGROUND: International consensus guidelines for the management of intraductal papillary mucinous neoplasms (IPMNs) of the pancreas provide several factors that can be used to predict which IPMNs will become malignant.The sensitivity of each factor's predictive accuracy, however, is relatively low, making it difficult to determine the appropriate treatment in individual cases. The aim of this study was to investigate whether increasing the number of predictive factors might augment the sensitivity of the established guidelines to detect malignant IPMNs.
METHODS: The medical records of 138 patients with IPMNs resected at our institution were reviewed. Possible malignant predictors were analyzed by univariate and multivariate analysis, and the effects of the number of factors and the predictive score of the pathologic results were examined. The cutoff points for the number of predictors to discriminate between malignant and nonmalignant IPMNs were established by constructing receiver operating characteristic curves.
RESULTS: A predictive analysis could not be carried out for the main duct IPMNs because of the high prevalence of malignancy and the small number of significant predictors associated with them. For malignant branch duct IPMNs, however, we identified 4 predictive factors that helped determine the correct diagnosis as follows: (1) the presence of a cyst ≥30 mm in diameter; (2) the presence of mural nodules; (3) a history of acute pancreatitis; and (4) atypical results of pancreatic juice cytology. An increase in the number of these factors significantly affected the sensitivity to predict malignancy. The area under the curve for the number of predictors for malignant branch duct IPMNs was 0.856, and the sensitivity and specificity were 96% and 71%, respectively, when the cutoff point was set at 2. The predictive scoring system also showed the same values of sensitivity and specificity for the number of factors.
CONCLUSION: Patients with branch duct IPMNs who have 2 or more of the 4 predictive factors described above should undergo standard pancreatectomy with lymph node dissection, whereas patients who present with 0 or 1 predictive factor can be treated by minimal pancreatectomy without nodal dissection or by careful observation without resection. All patients with main duct IPMNs, therefore, should be treated with resection as suspected malignancies.
Copyright © 2012 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21875733     DOI: 10.1016/j.surg.2011.07.009

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  22 in total

Review 1.  Natural History of Pancreatic Cysts.

Authors:  Alexander Larson; Richard S Kwon
Journal:  Dig Dis Sci       Date:  2017-03-17       Impact factor: 3.199

Review 2.  Current best practice and controversies in the follow up of patients with asymptomatic branch duct IPMN of the pancreas.

Authors:  Masao Tanaka
Journal:  HPB (Oxford)       Date:  2016-07-21       Impact factor: 3.647

3.  Interobserver agreement for detection of malignant features of intraductal papillary mucinous neoplasms of the pancreas on MDCT.

Authors:  Richard K G Do; Seth S Katz; Marc J Gollub; Jian Li; Jennifer LaFemina; Emily C Zabor; Chaya S Moskowitz; David S Klimstra; Peter J Allen
Journal:  AJR Am J Roentgenol       Date:  2014-11       Impact factor: 3.959

4.  Intraductal papillary mucinous neoplasm (IPMN) with high-grade dysplasia is a risk factor for the subsequent development of pancreatic ductal adenocarcinoma.

Authors:  Neda Rezaee; Carlotta Barbon; Ahmed Zaki; Jin He; Bulent Salman; Ralph H Hruban; John L Cameron; Joseph M Herman; Nita Ahuja; Anne Marie Lennon; Matthew J Weiss; Laura D Wood; Christopher L Wolfgang
Journal:  HPB (Oxford)       Date:  2015-12-10       Impact factor: 3.647

5.  Impact of surgery and surveillance in the management of branch duct intraductal papillary mucinous neoplasms of the pancreas according to Fukuoka guidelines: the Bologna experience.

Authors:  Riccardo Casadei; Claudio Ricci; Giovanni Taffurelli; Carlo Alberto Pacilio; Marina Migliori; Francesco Minni
Journal:  Updates Surg       Date:  2017-06-07

Review 6.  International consensus on the management of intraductal papillary mucinous neoplasm of the pancreas.

Authors:  Masao Tanaka
Journal:  Ann Transl Med       Date:  2015-11

7.  Accuracy of 2012 International Consensus Guidelines for the prediction of malignancy of branch-duct intraductal papillary mucinous neoplasms of the pancreas.

Authors:  Enrique Pérez-Cuadrado Robles; Frédérique Maire; Jérôme Cros; Marie-Pierre Vullierme; Vinciane Rebours; Alain Sauvanet; Alain Aubert; Safi Dokmak; Philippe Lévy; Philippe Ruszniewski
Journal:  United European Gastroenterol J       Date:  2016-01-06       Impact factor: 4.623

8.  Predictors of early stages of histological progression of branch duct IPMN.

Authors:  Hiroshi Kurahara; Kosei Maemura; Yuko Mataki; Masahiko Sakoda; Satoshi Iino; Yuko Kijima; Sumiya Ishigami; Shinichi Ueno; Hiroyuki Shinchi; Shoji Natsugoe
Journal:  Langenbecks Arch Surg       Date:  2014-12-03       Impact factor: 3.445

9.  Role of pancreatic juice cytology in the preoperative management of intraductal papillary mucinous neoplasm of the pancreas in the era of international consensus guidelines 2012.

Authors:  Takao Ohtsuka; Taketo Matsunaga; Hideyo Kimura; Yusuke Watanabe; Koji Tamura; Noboru Ideno; Teppei Aso; Yoshihiro Miyasaka; Junji Ueda; Shunichi Takahata; Takashi Osoegawa; Hisato Igarashi; Tetsuhide Ito; Yasuhiro Ushijima; Fumihiko Ookubo; Yoshinao Oda; Kazuhiro Mizumoto; Masao Tanaka
Journal:  World J Surg       Date:  2014-11       Impact factor: 3.352

10.  High-grade dysplasia and adenocarcinoma are frequent in side-branch intraductal papillary mucinous neoplasm measuring less than 3 cm on endoscopic ultrasound.

Authors:  Joyce Wong; Jill Weber; Barbara A Centeno; Shivakumar Vignesh; Cynthia L Harris; Jason B Klapman; Pamela Hodul
Journal:  J Gastrointest Surg       Date:  2012-09-05       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.